Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_provenance.
- NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_assertion description "[Consolidation biochemotherapy for patients with advanced nonsmall cell lung carcinoma responding to induction PVM (cisplatin, vinblastine, mitomycin-C) regimen. A phase II study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_provenance.
- NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_assertion evidence source_evidence_curated NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_provenance.
- NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_assertion SIO_000772 8635092 NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_provenance.
- NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_assertion wasDerivedFrom ctd_human-20150221 NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_provenance.
- NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_assertion wasGeneratedBy ECO_0000218 NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_provenance.
- ctd_human-20150221 importedOn "2015-02-21" NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_provenance.